1. Home
  2. PNTG vs INBX Comparison

PNTG vs INBX Comparison

Compare PNTG & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$35.70

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$111.28

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PNTG
INBX
Founded
2019
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
999.7M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
PNTG
INBX
Price
$35.70
$111.28
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$37.00
$150.00
AVG Volume (30 Days)
219.7K
586.3K
Earning Date
05-05-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
20.00
N/A
EPS
0.24
N/A
Revenue
$947,705,000.00
$1,300,000.00
Revenue This Year
$24.72
N/A
Revenue Next Year
$7.61
N/A
P/E Ratio
$153.50
N/A
Revenue Growth
36.31
550.00
52 Week Low
$21.74
$12.80
52 Week High
$37.54
$155.29

Technical Indicators

Market Signals
Indicator
PNTG
INBX
Relative Strength Index (RSI) 62.70 50.41
Support Level $28.05 $69.30
Resistance Level $37.54 $155.29
Average True Range (ATR) 1.76 13.20
MACD 0.49 -3.55
Stochastic Oscillator 73.32 23.22

Price Performance

Historical Comparison
PNTG
INBX

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: